我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • Read the study description and study information document.
  • Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability.

Study Description

New Zealand Clinical Research is trialing an investigational medication that is being developed for the treatment of fungal toenails (onychomycosis).

Onychomycosis is contagious fungal infection of the fingernails or toenails that causes discoloration, thickening, and separation from the nail bed. Onychomycosis affects about 6% to 8% of the adult population contributing to almost half of all nail problems. Onychomycosis is predominantly a cosmetic problem but can be uncomfortable and can lead to cellulitis (bacterial skin infection) or in severe cases detachment can occur.

Eradication of the infection is vital to improving appearance and avoiding these complications but is not easily accomplished due to the poor blood supply to nails. Current treatments have low effectiveness and low cure rates with a high chance of the infection returning. Therefore, there is an unmet need for effective treatment and eradication of onychomycosis.

ATB1651 is being developed by AmtixBio Co., Ltd. for the treatment of mild to moderate onychomycosis. ATB1651 is an antifungal agent that is able to penetrate the affected nail, ultimately preventing further fungi growth and potentially eradicating the onychomycosis.

 It is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

Requirements

Healthy Males and Females

  • Have a mild to moderate fungal toenail infection (onychomycosis) on at least one big toe
  • Aged between 18 – 70 years
  • BMI (Body Mass Index) between 17.5 kg/m2 – 35 kg/m2

What is Involved?

Study visits: 15 clinic visits

Reimbursement: Up to $200 before tax per visit

Important Documents

Important documents to download and read

Pre-screening Form

Hallux

Pre screening for Hallux

Personal details

Please provide your name, email and phone number so we can contact you
NZCR Site(Required)

Medical questions

Have you had any covid symptoms in the last two weeks or been in isolation?
Have you previously participated in a study with NZCR or any other organisation? Give details or leave blank if no
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Do you have any history of medical conditions relating to:
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Do you have (or think you may have) a toenail fungal infection (including at least one of your big toenails)?
If you feel comfortable doing so, are you able to send us a photograph of your toenail to assess eligibility?
Drop files here or
Max. file size: 16 MB.
    Are you currently using any topical anti-fungal or anti-inflammatory medications (medication applied to the skin) on your feet?
    Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 14 days?
    Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a back-up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
    I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.